Check-Cap Ltd.
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
22.2%
2 terminated/withdrawn out of 9 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses
Role: lead
Evaluation of C-Scan Capsule in Identifying Subjects With Elevated Risk of Colon Polyps
Role: lead
Evaluation of C-Scan in Identifying Subjects With Elevated Risk of Polyps in the Colon
Role: lead
Evaluation C-Scan System in Providing Structural Information and Polypoid Lesions in the Colon of Healthy Subjects
Role: lead
Development Study of Check-Cap Imaging System in Healthy Volunteers
Role: lead
Evaluation of Check-Cap C-Scan System in Providing Structural Information and Detection of Polypoid Lesions
Role: lead
Motility of the Check-cap's MD1 Colon Capsule in Subjects Following Colon Rectal Cancer Screening by Colonoscopy
Role: lead
Evaluation of C-Scan System in Providing Structural Information and Detection of Polypoid Lesions in High Risk Subjects
Role: lead
Feasibility of Check-Cap's P1 Capsule System Screening
Role: lead
All 9 trials loaded